CMS, FDA Announce RAPID Coverage Pathway to Accelerate Device Reimbursement
New pathway cuts red tape and brings predictability to Medicare coverage for Breakthrough Devices.
Tag Archives: reimbursement
Japan Reimbursement (Part 2): How to increase Japan reimbursement after receiving initial Japanese pricing
Many medical device companies want to go to Japan since it is the third-largest market in the world. Oftentimes, device companies want to register their devices quickly in Japan to be on the market and are not focused enough on the initial medical device reimbursement they will get. This can lead to an unprofitable business if the Japanese reimbursement price is not higher than the sales price in Japan. Are there strategies to increase reimbursement?
Japan Reimbursement (Part 1): What do you need to know about getting your medical device reimbursed in Japan?
Medical Devices must be fully reimbursable – no out of pocket expenses – in Japan. So, how is reimbursement achieved for your medical device?
Japan Medical Device Reimbursement Update 2024
Medical Device reimbursement levels in Japan are now more in line with the reimbursement levels in the EU. The Japanese government has pledged not to allow Japanese device reimbursement to be as high as the US prices.
Reimbursement Déjà Vu: Lessons for AI/ML Medtech Founders from the Molecular Diagnostics Industry
Payers demand robust evidence that molecular diagnostics and AI/ML technologies demonstrate clear ability to improve overall patient health or healthcare economics even if the technologies themselves don’t directly deliver the final outcome. This disconnect between a technology’s function and the desired long-term impact creates a hurdle for [innovators] to overcome when convincing payers of their value proposition.
How Real-World Evidence Helps Medical Device Manufacturers Drive Value
More and more, the quality of real-world evidence (RWE)—gathered from remote patient monitoring data, product and disease registry data, and patient feedback—determines whether a medical device is approved and, in some instances, for how long. Yet some medical device manufacturers are missing an important opportunity to collaborate with clinical registries in capturing this data and driving value.
Lace To Helm New RQM+ Reimbursement Division
“We are honored to have Dr. Lace, who is widely recognized as one of the industry’s most trusted reimbursement experts, leading our new division. He will also support all our services as our CMO.”
Telehealth Among Seniors: Drivers for Remote Care
A review of the top six reasons there has been a dramatic increase in the adoption of remote care among seniors.
Is China Still A Good Opportunity For Device Manufacturers?
The short answer is yes, but doing your homework in advance is now more important than ever.
China: A Huge Medical Device Market with Prospects and Challenges
China’s medical device market has grown significantly over the last five years, but with that growth comes some pitfalls.